The latest closing stock price for Enliven Therapeutics as of November 22, 2024 is 24.54.
An investor who bought $1,000 worth of Enliven Therapeutics stock at the IPO in 2023 would have $33 today, roughly 0 times their original investment - a 1.65% compound annual growth rate over 2 years.
The all-time high Enliven Therapeutics stock closing price was 29.55 on November 06, 2024.
The Enliven Therapeutics 52-week high stock price is 30.03, which is 22.4% above the current share price.
The Enliven Therapeutics 52-week low stock price is 9.80, which is 60.1% below the current share price.
The average Enliven Therapeutics stock price for the last 52 weeks is 20.38.
An investor who bought $1,000 worth of Enliven Therapeutics stock at the IPO in 2023 would have $33 today, roughly 0 times their original investment - a 1.65% compound annual growth rate over 2 years.
The all-time high Enliven Therapeutics stock closing price was 29.55 on November 06, 2024.
The Enliven Therapeutics 52-week high stock price is 30.03, which is 22.4% above the current share price.
The Enliven Therapeutics 52-week low stock price is 9.80, which is 60.1% below the current share price.
The average Enliven Therapeutics stock price for the last 52 weeks is 20.38.